Charles S. Wilcox

Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.

Alan D. Feiger, Ari Kiev, Ram Shrivastava et al. · PubMed · 1996 · 186 citations

A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety Disorder

Judith Bammert Adams, Robert E. Pyke, J Costa et al. · Journal of Clinical Psychopharmacology · 1995 · 79 citations

Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression

Alan D. Feiger, Robert J. Bielski, J. Douglas Bremner et al. · International Clinical Psychopharmacology · 1999 · 76 citations

Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.

Jay B. Cohn, Charles S. Wilcox · PubMed · 1986 · 68 citations

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +19

Predictors of placebo response: a retrospective analysis.

Charles S. Wilcox, Jay B. Cohn, Robert D. Linden et al. · PubMed · 1992 · 61 citations

Family Medicine, Behavioral Medicine, Placebo Response +12